Related references
Note: Only part of the references are listed.LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
Peter Sever et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association
Mary Cushman et al.
CIRCULATION (2021)
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction A Randomized, Controlled Trial
Are Annesonn Kalstad et al.
CIRCULATION (2021)
Sex Differences Remain Under-Reported in Cardiovascular Publications
Stephani C. Wang et al.
JOURNAL OF WOMENS HEALTH (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis
Fahimeh Ramezani Tehrani et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2020)
Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology*
Massimo F. Piepoli et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Sex Disparities in Cardiovascular Outcome Trials of Populations With Diabetes: A Systematic Review and Meta-analysis
Kristin K. Clemens et al.
DIABETES CARE (2020)
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women JACC State-of-the-Art Review
Leslie Cho et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs
Muhammad Shahzeb Khan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta-Analysis
Min Zhao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Impact of statin use on cancer-specific mortality and recurrence A meta-analysis of 60 observational studies
Jing Yang et al.
MEDICINE (2020)
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
Maciej Banach et al.
JAMA CARDIOLOGY (2020)
Participation of Women and Older Participants in Randomized Clinical Trials of Lipid-Lowering Therapies A Systematic Review
Safi U. Khan et al.
JAMA NETWORK OPEN (2020)
Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review
Kelvin Okoth et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention
Petal Elder et al.
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience
Muhammed T. Gurgoze et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Ulrich Laufs et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Unique cardiovascular risk factors in women
Laura Young et al.
HEART (2019)
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation
Julie J. Lee et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Sex Differences in the Use of Statins in Community Practice Patient and Provider Assessment of Lipid Management Registry
Michael G. Nanna et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data
Dongshan Zhu et al.
LANCET PUBLIC HEALTH (2019)
Immunity and Inflammation in Atherosclerosis
Dennis Wolf et al.
CIRCULATION RESEARCH (2019)
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies
Lisa Pennells et al.
EUROPEAN HEART JOURNAL (2019)
Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway
Amanda R. Markovitz et al.
EUROPEAN HEART JOURNAL (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: a retrospective cohort study
Safyer McKenzie-Sampson et al.
ACTA DIABETOLOGICA (2018)
Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease
Margo B. Minissian et al.
CIRCULATION (2018)
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association
Laxmi S. Mehta et al.
CIRCULATION (2018)
Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors
Cyril Breuker et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Participation of Women in Clinical Trials Not Yet Time to Rest on Our Laurels
Louise Pilote et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs
Pamela E. Scott et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States
Sanne A. E. Peters et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis
Eliot A. Brinton et al.
JOURNAL OF WOMENS HEALTH (2018)
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study
Romana Pylypchuk et al.
LANCET (2018)
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980793 adults from 68 prospective studies
Louisa Gnatiuc et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Sex differences in lipid and lipoprotein metabolism
Brian T. Palmisano et al.
MOLECULAR METABOLISM (2018)
The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women
Simon Timpka et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2018)
Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction
Jennifer J. Stuart et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative
Samia Mora et al.
JAMA INTERNAL MEDICINE (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China
Fiona Bragg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
POST-TRANSITIONAL FERTILITY: THE ROLE OF CHILDBEARING POSTPONEMENT IN FUELLING THE SHIFT TO LOW AND UNSTABLE FERTILITY LEVELS
Tomas Sobotka
JOURNAL OF BIOSOCIAL SCIENCE (2017)
Gender differences in the effects of cardiovascular drugs
J. Tamargo et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2017)
Comparison of Adherence to Guideline-Based Cholesterol Treatment Goals in Men Versus. Women
Martin W. Schoen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
The relationship between coronary atherosclerosis and body fat distribution measured using dual energy X-ray absorptiometry
Se-Jun Park et al.
ATHEROSCLEROSIS (2016)
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science A Scientific Statement From the American Heart Association
Jean C. McSweeney et al.
CIRCULATION (2016)
Statin Adherence: Does Gender Matter?
Karen M. Goldstein et al.
CURRENT ATHEROSCLEROSIS REPORTS (2016)
Statin-induced myopathy in a usual care setting-a prospective observational study of gender differences
Ilona Skilving et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology
Delphine De Smedt et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women A Meta-analysis
Maryam Kavousi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study
Dean G. Karalis et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
The risks of statin use in pregnancy: A systematic review
Dean G. Karalis et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population
Jamal S. Rana et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Advances in Lipid Therapy: The Role of Lipid Treatment in Women in Primary Prevention
Martha Gulati et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease
Kshipra Hemal et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis
Luqian Zhao et al.
ONCOTARGET (2016)
Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality A Systematic Review and Meta-analysis
Taulant Muka et al.
JAMA CARDIOLOGY (2016)
Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis
Jeanine E. Roeters van Lennep et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence Problem for Young Women
Kate Smolina et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Menopausal stages and non-alcoholic fatty liver disease in middle-aged women
Seungho Ryu et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2015)
Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction The VIRGO Study
Erica C. Leifheit-Limson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
Jordan Fulcher et al.
LANCET (2015)
Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence Problem for Young Women
Kate Smolina et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol
Moumita Ghosh et al.
JOURNAL OF LIPID RESEARCH (2015)
Understanding Disparities in Lipid Management Among Patients with Type 2 Diabetes: Gender Differences in Medication Nonadherence after Treatment Intensification
John Billimek et al.
WOMENS HEALTH ISSUES (2015)
Gender Differences in Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease
Brett M. Victor et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events
Sanne A. E. Peters et al.
DIABETOLOGIA (2014)
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Michael C. d'Emden et al.
DIABETOLOGIA (2014)
Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations
Paul Muntner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort
Maryam Kavousi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Influence of Patient Sex and Gender on Medication Use, Adherence, and Prescribing Alignment with Guidelines
Marie Manteuffel et al.
JOURNAL OF WOMENS HEALTH (2014)
Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
Martin J. Landray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy Insights From SATURN
Rishi Puri et al.
JACC-CARDIOVASCULAR IMAGING (2014)
Narrowing Sex Differences in Lipoprotein Cholesterol Subclasses Following Mid-Life: The Very Large Database of Lipids (VLDL-10B)
Kristopher J. Swiger et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Gender and racial disparities in adherence to statin therapy: A meta-analysis
Jennifer Lewey et al.
AMERICAN HEART JOURNAL (2013)
Prospective Analysis of Association between Statin Use and Breast Cancer Risk in the Women's Health Initiative
Pinkal Desai et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Estrogen Treatment After Ovariectomy Protects Against Fatty Liver and May Improve Pathway-Selective Insulin Resistance
Lin Zhu et al.
DIABETES (2013)
The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport
Robert M. Badeau et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat
Hua Zhang et al.
JOURNAL OF LIPID RESEARCH (2013)
Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease
Christian Dempe et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2013)
Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
Annie L. Culver et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Statin Therapy in the Prevention of Recurrent Cardiovascular Events
Jose Gutierrez et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Meta-Analysis of Statin Effects in Women Versus Men
William J. Kostis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Biochemical Cardiovascular Risk Factors After Hypertensive Pregnancy Disorders: A Systematic Review and Meta-analysis
Wietske Hermes et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2012)
Benefit of Intensive Statin Therapy in Women Results From PROVE IT-TIMI 22
Quynh A. Truong et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies
Rachel R. Huxley et al.
LANCET (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Transcriptional Profiling of Human Liver Identifies Sex-Biased Genes Associated with Polygenic Dyslipidemia and Coronary Artery Disease
Yijing Zhang et al.
PLOS ONE (2011)
Statins and All-Cause Mortality in High-Risk Primary Prevention A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants
Kausik K. Ray et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials
Samia Mora et al.
CIRCULATION (2010)
Twelve-Year Follow-Up of American Women's Awareness of Cardiovascular Disease Risk and Barriers to Heart Health
Lori Mosca et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
Mario Petretta et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: A Report From the Women's Ischemia Syndrome Evaluation (WISE)
Vera Bittner et al.
AMERICAN HEART JOURNAL (2009)
Women and Ischemic Heart Disease Evolving Knowledge
Leslee J. Shaw et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women
Nirupa R. Matthan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study
N. K. Wenger et al.
HEART (2008)
Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in Norfolk cohort - A population-based prospective study
Dexter Canoy et al.
CIRCULATION (2007)
Coronary artery calcium scores and risk for cardiovascular events in women classified as low risk based on framingham risk score
Susan G. Lakoski et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Primary prevention of cardiovascular diseases among hypercholesterolemic Japanese with a low dose of pravastatin
H. Nakamura
ATHEROSCLEROSIS SUPPLEMENTS (2007)
Women produce fewer but triglyceride-richer very low-density lipoproteins than men
Faidon Magkos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score
Paul M. Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Statin safety: Lessons from new drug applications for marketed statins
TA Jacobson
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
R Huxley et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women
ED Michos et al.
ATHEROSCLEROSIS (2006)
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Haruo Nakamura et al.
LANCET (2006)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
N Jochmann et al.
EUROPEAN HEART JOURNAL (2005)
Physicians' attitudes toward preventive therapy for coronary artery disease: Is there a gender bias?
A Abuful et al.
CLINICAL CARDIOLOGY (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes
AL Blomkalns et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Gender difference in the impact of type 2 diabetes on coronary heart disease risk
A Juutilainen et al.
DIABETES CARE (2004)
The distribution of 10-year risk for coronary heart disease among US adults - Findings from the National Health and Nutrition Examination Survey III
ES Ford et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Drug treatment of hyperlipidemia in women
JME Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Prevention and rehabilitation - Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study
W Hague et al.
AMERICAN HEART JOURNAL (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Overweight and obesity as determinants of cardiovascular risk - The Framingham experience
PWF Wilson et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
ACC/AHA/NHLBI clinical advisory on the use and safety of statins
RC Pasternak et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Arsenic toxicity and potential mechanisms of action
MF Hughes
TOXICOLOGY LETTERS (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
HDL particle size:: A marker of the gender difference in the metabolic risk profile
A Pascot et al.
ATHEROSCLEROSIS (2002)
Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial
W Insull et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2000)
Share Paper
